Rapid analysis of Saposhnikovia divaricate decoction metabolism in rats by UHPLC–Q‐TOFMS and multivariate statistical analysis. (17th January 2020)

• Record Type: Journal Article
• Authors: Li, Yueyue; Zhao, Liang; Lv, Diya; Wang, Rong; Zhu, Zhenyu; Yuan, Yongfang
• Is Part Of: Biomedical chromatography. Volume 34:Number 3(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-01-17
• Subjects: metabolism -- multivariate statistical analysis -- Saposhnikovia divaricate -- UHPLC–Q‐TOFMS; Chromatographic analysis -- Periodicals; Biology -- Periodicals; Medicine -- Periodicals; Biology -- Periodicals; Chromatography -- methods -- Periodicals; Medicine -- Periodicals; 543.089
• DOI: 10.1002/bmc.4778
• Languages: English
• ISSNs: 0269-3879

Abstract

Abstract: Saposhnikovia divaricata is a commonly used traditional Chinese medicine in treating various diseases such as pyrexia, rheumatism and headache. So far, there have been few reports on the metabolism of orally administered Saposhnikovia divaricate decoction (SDD), hindering further study on its bioactive components and their pharmacological characteristics. In the present study, ultra‐performance liquid chromatography–quadrupole time‐of‐flight mass spectrometry (UHPLC–Q‐TOFMS) was used coupled with principal component analysis (PCA) and partial least squared discriminant analysis (PLS‐DA) to rapidly discover and identify the metabolites of SDD. According to the result of PLS‐DA, a total of 139 ions of interest including 87 positive ions and 52 negative ions were extracted as SDD‐related xenobiotics in urine. Finally, 12 and 65 compounds were identified as absorbed parent components and metabolites of SDD, respectively. Among them, 40 new metabolites were reported for the first time. Our results suggested that hydrolysis, hydroxylation, glucuronidation and sulfation are the major metabolic pathways of chromones, while hydroxylation, hydrogenation and sulfation are the main metabolic pathways of coumarins. This study is the first to explore the absorption and metabolism of SDD using UHPLC–Q‐TOFMS, with results providing a basis for further study of its pharmacokinetics and discovery of its bioactive components.